Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pendyala

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Methods in Molecular Medicine|February 23, 2011
RT-PCR Quantitation of HSP60 mRNA ExpressionR P Perez, L Pendyala, Z Elakawi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Effect of glutathione depletion on the cytotoxicity of cisplatin and iproplatin in a human melanoma cell lineL Pendyala, R Perez, A Weinstein, et al.
Cancer Chemotherapy and Pharmacology|January 5, 2002
In vitro studies on the mechanisms of oxaliplatin resistanceS Hector, W Bolanowska-Higdon, J Zdanowicz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Pharmacokinetics of Anandron in patients with advanced carcinoma of the prostateL Pendyala, P J Creaven, R Huben, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Intracellular glutathione and cytotoxicity of platinum complexesL Pendyala, P J Creaven, R Perez, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancerL Pendyala, W Greco, J W Cowens, et al.
Progress in Clinical and Biological Research|January 1, 1987
Clinical pharmacokinetics of a new antiandrogen Anandron (RU 23908)L Pendyala, P J Creaven, R Huben, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
DNA binding of iproplatin and its divalent metabolite cis-dichloro-bis-isopropylamine platinum (II)L Pendyala, A V Arakali, P Sansone, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Evaluation of the nephrotoxicity of iproplatin (CHIP) in comparison to cisplatin by the measurement of urinary enzymesL Pendyala, S Madajewicz, S B Lele, et al.
Cancer Letters|April 1, 2008
Relationship between heat shock protein 60 (HSP60) mRNA expression and resistance to platinum analogues in human ovarian and bladder carcinoma cell linesM Abu-Hadid, J D Wilkes, Z Elakawi, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Methods in Molecular Medicine|February 23, 2011
RT-PCR Quantitation of HSP60 mRNA ExpressionR P Perez, L Pendyala, Z Elakawi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Effect of glutathione depletion on the cytotoxicity of cisplatin and iproplatin in a human melanoma cell lineL Pendyala, R Perez, A Weinstein, et al.
Cancer Chemotherapy and Pharmacology|January 5, 2002
In vitro studies on the mechanisms of oxaliplatin resistanceS Hector, W Bolanowska-Higdon, J Zdanowicz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Pharmacokinetics of Anandron in patients with advanced carcinoma of the prostateL Pendyala, P J Creaven, R Huben, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Intracellular glutathione and cytotoxicity of platinum complexesL Pendyala, P J Creaven, R Perez, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancerL Pendyala, W Greco, J W Cowens, et al.
Progress in Clinical and Biological Research|January 1, 1987
Clinical pharmacokinetics of a new antiandrogen Anandron (RU 23908)L Pendyala, P J Creaven, R Huben, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
DNA binding of iproplatin and its divalent metabolite cis-dichloro-bis-isopropylamine platinum (II)L Pendyala, A V Arakali, P Sansone, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Evaluation of the nephrotoxicity of iproplatin (CHIP) in comparison to cisplatin by the measurement of urinary enzymesL Pendyala, S Madajewicz, S B Lele, et al.
Cancer Letters|April 1, 2008
Relationship between heat shock protein 60 (HSP60) mRNA expression and resistance to platinum analogues in human ovarian and bladder carcinoma cell linesM Abu-Hadid, J D Wilkes, Z Elakawi, et al.
Pageof 6